BOSTON IMMUNE TECHNOLOGIES & THERAPEUTICS

boston-immune-technologies-therapeutics-logo

BITT has developed a platform for targeting the tumor necrosis factor receptor 2 (TNFR2) oncogene and the potent population of TNFR2 Tregs in the tumor microenvironment.
#People #Financial #Website #More

BOSTON IMMUNE TECHNOLOGIES & THERAPEUTICS

Industry:
Biotechnology Therapeutics

Founded:
2011-01-01

Address:
Winchester, Virginia, United States

Country:
United States

Website Url:
http://www.bostonimmunetech.com

Total Employee:
1+

Status:
Active

Total Funding:
10 M USD

Technology used in webpage:
SPF Content Delivery Network Font Awesome Microsoft Exchange Online Office 365 Mail IPv6 BootstrapCDN Cloudflare Hosting Cloudflare DNS



Current Advisors List

sheila-mikhail_image

Sheila Mikhail Business Advisor @ Boston Immune Technologies & Therapeutics
Advisor

Current Employees Featured

russell-lamontagne_image

Russell LaMontagne
Russell LaMontagne Co-Founder, Chief Executive Officer & President @ Boston Immune Technologies & Therapeutics
Co-Founder, Chief Executive Officer & President
2014-02-01

Founder


denise-faustman_image

Denise Faustman

russell-lamontagne_image

Russell LaMontagne

Investors List

beigene_image

BeiGene

BeiGene investment in Series A - Boston Immune Technologies & Therapeutics

hatteras-venture-partners_image

Hatteras Venture Partners

Hatteras Venture Partners investment in Series A - Boston Immune Technologies & Therapeutics

Official Site Inspections

http://www.bostonimmunetech.com Semrush global rank: 5.42 M Semrush visits lastest month: 1.56 K

  • Host name: 172.67.194.126
  • IP address: 172.67.194.126
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Boston Immune Technologies & Therapeutics" on Search Engine

dfkcompany.com © 2022. All rights reserved